Article Details

State Street Corp Invests $7.55 Million in BridgeBio Pharma (NASDAQ:BBIO)

Retrieved on: 2019-12-26 20:11:15

Tags for this article:

Click the tags to see associated articles and topics

State Street Corp Invests $7.55 Million in BridgeBio Pharma (NASDAQ:BBIO). View article details on hiswai:

Excerpt

<div><b>Kohlberg Kravis Roberts</b> & Co. L.P. acquired a new stake in BridgeBio Pharma during the second quarter worth about $995,211,000. Viking Global ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo